Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for CYP2D6 and CYP2C19 Genotypes and Dosing of Selective Serotonin Reuptake Inhibitors. [electronic resource]
Producer: 20151008Description: 127-34 p. digitalISSN:- 1532-6535
- Biotransformation
- Cytochrome P-450 CYP2C19 -- genetics
- Cytochrome P-450 CYP2D6 -- genetics
- Drug Dosage Calculations
- Genotype
- Humans
- Patient Safety
- Pharmacogenetics -- standards
- Phenotype
- Polymorphism, Genetic
- Risk Assessment
- Risk Factors
- Selective Serotonin Reuptake Inhibitors -- administration & dosage
No physical items for this record
Publication Type: Journal Article; Practice Guideline; Research Support, N.I.H., Extramural
There are no comments on this title.
Log in to your account to post a comment.